Collection: Reduced Carcinogens

Despite many experts’ concerns that so-called “reduced risk” cigarettes would only serve to hinder future cigarette reform, prevent smokers from quitting, and encourage new smokers to pick up the habit, three major tobacco companies decided to release such cigarettes, boasting ludicrous, unsubstantiated health claims. Though tobacco companies had been secretly researching reduced risk cigarettes for decades, their first public approach only began in the late 1980s. In 1988, R.J. Reynolds released Premier, the predecessor to Eclipse cigarettes. Premier only remained on the market for one year and was pulled in 1989 due to its unpopularity. In 1995, R,J. Reynolds released a similar brand, Eclipse, in test markets, and eventually made the brand available in all markets in 2000. Also in 2000, Brown & Williamson released their answer in the form of Advance Lights. The next year, in 2001, Vector (related to Liggett Group), released Omni cigarettes. All three brands employed different technologies to present a cigarette that had the potential to create fewer health side effects, though none had scientific proof for such claims.

Out of the three brands, R.J. Reynolds’ Eclipse is the only one that remains in production today; the other two brands were discontinued after a few unsuccessful years at market. Eclipse is unique in that it uses a carbon tip which heats the tobacco, rather than burning it. This heating effect, which was also used by its R.J. Reynolds predecessor, Premier, releases a vapor, giving off less smoke than leading cigarettes. Thus, at a time when second-hand smoking was of increasing public concern and when smoking was beginning to be banned in more and more public places across the United States, R.J. Reynolds positioned its newest cigarette as friendlier for smokers who wanted to smoke inoffensively around non-smokers. Ultimately, Eclipse was advertised as emitting “nearly 90% less second hand smoke.” R.J. Reynolds also claimed health benefits for the smoker, asserting that Eclipse “may present less risk of cancer associated with smoking.” The Eclipse advertisement copy has come under attack for its misleading health claims. In particular, its claim that there exists a “next-best” choice to quitting has many up in arms: “The best choice for smokers who worry about their health is to quit. The next best choice is Eclipse,” the ads say.

Brown & Williamson’s Advance Lights claimed “all of the taste…less of the toxins” in their advertisements. They, too, implied that the ideal situation would be for a smoker to quit, but called Advance “a step in the right direction.” Advance’s three-part filter and special curing methods were said to reduce levels of nitrosamines (well-known causes of lung cancer) and reduce “toxic gases.” The Advance ads looked more like advertisements for contact lenses than cigarettes, with a blue and white color scheme, straightforward text and diagrams, and a close-up of a person’s eye looking directly at the viewer with a no-nonsense approach. Advance cigarettes were discontinued in 2004.

Vector’s Omni was perhaps the most shocking of the three risk reduction brands, claiming “reduced carcinogens” while maintaining “premium taste.” Discontinued in 2006, Omni promised to taste and burn like a premium cigarette, but to “significantly reduce carcinogens that are among the major causes of lung cancer,” in particular polycyclic aromatic hydrocarbons (PAHs), nitrosamines, and catechols. However, the amount of reduction was extremely unclear – the reported reduction in PAHs was between 15% and 60%, a huge margin of difference. It is also important to note that whereas Omni claims to reduce risks of lung cancer, it fails to even mention other common and fatal smoking-related illnesses like heart disease and emphysema.

Despite many experts’ concerns that so-called “reduced risk” cigarettes would only serve to hinder future cigarette reform, prevent smokers from quitting, and encourage new smokers to pick up the habit, three major tobacco companies decided to release such cigarettes, boasting ludicrous, unsubstantiated health claims. Though tobacco companies had been secretly researching reduced risk cigarettes for decades, their first public approach only began in the late 1980s. In 1988, R.J. Reynolds released Premier, the predecessor to Eclipse cigarettes. Premier only remained on the market for one year and was pulled in 1989 due to its unpopularity. In 1995, R,J. Reynolds released a similar brand, Eclipse, in test markets, and eventually made the brand available in all markets in 2000. Also in 2000, Brown & Williamson released their answer in the form of Advance Lights. The next year, in 2001, Vector (related to Liggett Group), released Omni cigarettes. All three brands employed different technologies to present a cigarette that had the potential to create fewer health side effects, though none had scientific proof for such claims.

Out of the three brands, R.J. Reynolds’ Eclipse is the only one that remains in production today; the other two brands were discontinued after a few unsuccessful years at market. Eclipse is unique in that it uses a carbon tip which heats the tobacco, rather than burning it. This heating effect, which was also used by its R.J. Reynolds predecessor, Premier, releases a vapor, giving off less smoke than leading cigarettes. Thus, at a time when second-hand smoking was of increasing public concern and when smoking was beginning to be banned in more and more public places across the United States, R.J. Reynolds positioned its newest cigarette as friendlier for smokers who wanted to smoke inoffensively around non-smokers. Ultimately, Eclipse was advertised as emitting “nearly 90% less second hand smoke.” R.J. Reynolds also claimed health benefits for the smoker, asserting that Eclipse “may present less risk of cancer associated with smoking.” The Eclipse advertisement copy has come under attack for its misleading health claims. In particular, its claim that there exists a “next-best” choice to quitting has many up in arms: “The best choice for smokers who worry about their health is to quit. The next best choice is Eclipse,” the ads say.

Brown & Williamson’s Advance Lights claimed “all of the taste…less of the toxins” in their advertisements. They, too, implied that the ideal situation would be for a smoker to quit, but called Advance “a step in the right direction.” Advance’s three-part filter and special curing methods were said to reduce levels of nitrosamines (well-known causes of lung cancer) and reduce “toxic gases.” The Advance ads looked more like advertisements for contact lenses than cigarettes, with a blue and white color scheme, straightforward text and diagrams, and a close-up of a person’s eye looking directly at the viewer with a no-nonsense approach. Advance cigarettes were discontinued in 2004.

Vector’s Omni was perhaps the most shocking of the three risk reduction brands, claiming “reduced carcinogens” while maintaining “premium taste.” Discontinued in 2006, Omni promised to taste and burn like a premium cigarette, but to “significantly reduce carcinogens that are among the major causes of lung cancer,” in particular polycyclic aromatic hydrocarbons (PAHs), nitrosamines, and catechols. However, the amount of reduction was extremely unclear – the reported reduction in PAHs was between 15% and 60%, a huge margin of difference. It is also important to note that whereas Omni claims to reduce risks of lung cancer, it fails to even mention other common and fatal smoking-related illnesses like heart disease and emphysema.